Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03311867 · ClinicalTrials.gov registry record · NA
Prolene Versus Ethibond for Cervical Cerclage
A NA study, sponsored by Rutgers University.
- Completed
- Registry status
- NA
- Development phase
- 16
- Enrollment target
NCT03311867 is a NA study that has completed, run by Rutgers University. The registered enrollment target is 16 participants.
The verdict
NCT03311867, a NA study, has completed, sponsored by Rutgers University.
- COMPLETED
- Registry status
- NA
- Development phase
- 16 participants
- Enrollment target
Study Summary
The purpose of the proposed study is to examine the relationship between cerclage suture material of Ethibond and Prolene and its effect on the vaginal microbiome in a prospective randomized control trial. Ethibond is another commonly used suture material for performing cervical cerclage that shares some characteristics with previously studied suture materials. It is braided like the Mersilene, but thinner like the monofilament Prolene. The investigators will study whether Ethibond causes the vaginal microbiome to be adversely affected like Mersilene or whether there is a healthy microbiome like Prolene. This study will allow the investigators to determine whether it is advisable to continue to use Ethibond for cervical cerclage in clinical practice, or whether obstetricians should avoid its use as now done with Mersilene.
Interventions
- OTHER Ethibond Suture
- OTHER Prolene Suture
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2017-08-01 |
| Est. Completion | 2019-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03311867
The ClinicalTrials.gov registry entry for NCT03311867 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rutgers University, which has 18 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Ethibond Suture is the first listed.
NCT03311867 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03311867 about?
NCT03311867 is a clinical study titled "Prolene Versus Ethibond for Cervical Cerclage". The purpose of the proposed study is to examine the relationship between cerclage suture material of Ethibond and Prolene and its effect on the vaginal microbiome in a prospective randomized control trial. Ethibond is another commonly used suture material for performing cervical cerclage that shares...
What is the current status of trial NCT03311867?
This trial is currently completed. It is a NA study. The enrollment target is 16 participants. The study started on 2017-08-01. Estimated completion is 2019-12-31.
What interventions are being tested in trial NCT03311867?
The interventions under investigation include: Ethibond Suture (OTHER), Prolene Suture (OTHER).
Who is sponsoring clinical trial NCT03311867?
This trial is sponsored by Rutgers University, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.